biomea fusion
Neil Squires is currently employed as a Senior Scientist at Biomea Fusion since April 2021. Prior to this, Neil held the position of Senior Associate Scientist at Gilead Sciences from June 2005 to 2021. Neil's career started as a Research Associate at Celera Corporation from 1999 to 2005. Neil obtained a Master of Science (MSc) in Chemistry from the University of Ottawa in 1998, following a Bachelor of Science (BSc) in Chemistry from Memorial University of Newfoundland in 1996.
biomea fusion
Biomea Fusion, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically defined cancers. The company was formed in 2017 by a small group of biotech executives that came together with the common goal of achieving better therapies for patients.